Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H)
Clinical trial NCT06400238 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06400238
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2023-01-27
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.